Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 19, 2020 at 04:59 am EDT
Share
Guangxi Liuzhou Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 7,572.866 million compared to CNY 7,196.922 million a year ago. Operating income was CNY 494.504 million compared to CNY 461.003 million a year ago. Net income was CNY 394.874 million compared to CNY 356.155 million a year ago. Basic earnings per share from continuing operations was CNY 1.09 compared to CNY 0.98 a year ago.
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and processing of traditional Chinese medicine pieces and traditional Chinese medicine formula granules. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services and others.
GUANGXI LIUYAO GROUP CO., LTD 
